山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (2): 90-95.doi: 10.6040/j.issn.1673-3770.0.2016.146

• 论著 • 上一篇    下一篇

甘糖酯对糖尿病大鼠视网膜病变中血管生成因子VEGF表达的影响

周玮琰1,王洪亚2,杜秀娟3,董卫红1   

  1. 1.山东大学附属省立医院眼科;
    2.山东大学附属省立医院检验科, 山东 济南 250021;
    3.山东中医药大学眼科中心 山东施尔明眼科医院, 山东 济南 250002
  • 收稿日期:2016-04-01 出版日期:2017-04-16 发布日期:2017-04-16
  • 通讯作者: 董卫红. E-mail:dongwh69@163.com
  • 基金资助:
    山东省科学技术发展计划(2010G0020239);山东省优秀中青年科学家科研奖励基金(BS2014YY060)

Effects of PGMS on the expression of vascular endothelial growth factor in the rat of diabetic retinopathy.

  1. 1. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;2. Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;3. Eye Center of Shandong University of Traditional Chinese Medicine, Shandong Shierming Eye Hospital, Jinan 250002, Shandong, China
  • Received:2016-04-01 Online:2017-04-16 Published:2017-04-16

HTML

PDF (PC)

316

摘要： 目的 探讨甘糖酯对糖尿病大鼠视网膜病变(DR)中血管内皮生长因子(VEGF)表达变化的影响,为将甘糖酯应用于临床上防治DR提供可靠的理论和实验依据。 方法 选取清洁级雄性成年Wistar大鼠随机分为正常对照组,实验对照组,甘糖酯治疗组,其中甘糖酯治疗组分为糖尿病+低甘糖酯组(50 mg/kg甘糖酯)和糖尿病+高甘糖酯组(100 mg/kg甘糖酯)。大鼠采用链脲佐菌素60 mg/kg一次性腹腔内注射制作糖尿病模型,甘糖酯治疗组的给药方法为甘糖酯溶液灌胃,持续12周。给药12周后处死各组大鼠并分离视网膜,取房水、血清,用ELISA法检测大鼠视网膜组织、房水及血清中VEGF蛋白的表达变化情况,免疫组化检测大鼠视网膜VEGF蛋白表达的变化及表达位置,实时定量PCR检测大鼠视网膜VEGF mRNA表达变化情况。 结果 给药12周后大鼠DR模型中,甘糖酯对大鼠的血糖没有影响,ELISA检测结果表明,各组大鼠血清中的VEGF蛋白差异没有统计学意义(P>0.05),而糖尿病组大鼠房水及视网膜中的VEGF蛋白含量与正常对照组比较显著增加(P<0.05),甘糖酯干预后房水及视网膜中VEGF蛋白较糖尿病组表达明显降低(P<0.05)。免疫组化检测表明,正常对照组VEGF蛋白呈低表达,糖尿病组VEGF蛋白呈高表达状态,主要在视网膜神经节细胞层、内从状层及外核层高表达;而给予甘糖酯干预后VEGF蛋白呈弱表达。实时定量PCR检测大鼠视网膜中VEGF mRNA,可见正常对照组VEGF mRNA为低表达状态,糖尿病组VEGF mRNA的表达为正常对照组的2.12倍,甘糖酯干预后视网膜VEGF mRNA表达较糖尿病组明显下降(P<0.05)。 结论 甘糖酯对大鼠早期DR有很好的防治作用,其机制与抑制血管生成因子VEGF的表达与分泌有关。

关键词: 甘糖酯, 血管内皮生长因子, 糖尿病视网膜病变

Abstract: Objective To investigate the influence of propylene glycol mannate sulfate(PGMS)on the expression of vascular endothelial growth factor(VEGF)in diabetic retinopathy(DR)by a rat model, to study the mechanism of PGMS againstDR, and to provide a reliable theoretical and experimental evidence for the PGMs to be applied to clinical prevention and treatment of DR. Methods Male Wistar rats were randomized into the normal control group, the diabetic control group and the PGMS group. The PGMS group was subdivided into the low-dose PGMS group and high-dose PGMS group, with doses of 50 mg/kg and 100 mg/kg, respectively. The 1% Streptozotocin(STZ)of 60 mg/kg was intraperitoneally injected in rats to establish the diabetic models. The PGMS with the doses of 50 mg/kg and 100 mg/kg were used to gavage in different groups of models for 12 weeks. Twelve weeks later, the animals were sacrificed and retinas were isolated. The aqueous humor and serum were taken, expressions of VEGF protein in retina, aqueous humor and serum were detected by ELISA, respectively. The location and the expression of VEGF protein in 山东大学耳鼻喉眼学报31卷2期 -周玮琰,等.甘糖酯对糖尿病大鼠视网膜病变中血管生成因子VEGF表达的影响 \=-retina tissue was detected by immune-histochemistry. Real-time RT-PCR was used to measure the expression of VEGF mRNA in retinas. Results Twelve weeks after the use of PGMS,the level of blood glucose was not changed. ELISA showed that the expression of VEGF protein in serum was not significantly changed in different groups(P>0.05), but the expression of VEGF protein in aqueous humor and retina was significantly increased in diabetic control group than normal control group(P<0.05), but the groups which PGMS was given reduced, lower than that DM group, showing statistically significant differences(P<0.05). Immunohistochemistry showed that the VEGF protein was almost not expressed in normal control group, but the VEGF protein was highly expressed in diabetic control group. The expression mainly located in the ganglion cell layer, the inner plexiform layer, outer nuclear layer. The VEGF protein was weakly expressed at the group of PGMS. Real-time RT-PCR showed the expression of VEGF mRNA was lower in normal control group. The expression of VEGF mRNA in diabetic control group was almost 2.12 times than normal control group. The expression was decreased obviously in the group of PGMS. Conclusion PGMs has a good control effect on early diabetic retinopathy. PGMS can treat the diabetic retinopathy by downregulating the expressions of VEGF in early diabetic retinopathy.

Key words: Diabetic retinopathy, Vascular endothelial growth factor, Propylene glycol mannate sulfate

中图分类号: 

  • R774
[1] Osaadon P, Fagan XJ, Lifshitz T, et al. A review of anti-VEGF agents for proliferative diabetic retinopathy[J]. Eye(Lond), 2014, 28(5):510-520.
[2] Cancarini A, Costagliola C, Dell'omo R, et al. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy[J]. Minerva Endocrinol, 2014, 39(4):305-311.
[3] 巨丹. 甘糖酯对Ⅰ型糖尿病治疗前后血脂、血液流变学变化[J]. 中国血液流变学杂志, 2004, 14(2):198-216.
[4] 王哲, 初奎臣, 高聆, 等. 甘糖酯对实验糖尿病大鼠粘附分子-CD54、CD106、CD62P的影响[J].中国海洋药物, 2003, 22(3):43-47. WANG Zhe, CHU Kuichen, GAO Ling, et al. Effects of Propylene Glycol Mannate Sulfate on Adhesion Mole- CUles-Cd54、 cd106、 cd62pin Diabetic Rats[J]. Chin J Marine Drugs, 2003, 22(3):43-47.
[5] 孔磊, 高聆, 赵家军. 2型糖尿病患者外周血粘附分子变化及甘糖酯干预治疗的初步研究[J]. 山东医药, 2002, 42(5):1-3. KONG Lei, GAO Ling, ZHAO Jiajun. Determination of adhesion molecules in patients with type 2 diabetes mellitus and primary study of curative effect of propylene glycol mannate sulfate[J]. Shandong Med J, 2002, 42(5):1-3.
[6] 王汝霞, 胡建廷, 高聆, 等. 甘糖酯降低实验性糖尿病大鼠肾脏ICAM-1,VCAM-1表达[J]. 中国海洋药物, 2005, 24(1):10-16. WANG Ruxia, HU Jianting, GAO Ling, et al. Propylene glycol mannate sulfate down-regulated the expression of adhesion molecules(icam-1, vcam-1)in kidney of diabetic rats[J]. Chin J Marine Drugs, 2005, 24(1):10-16.
[7] 陈晓, 路新枝, 高焱, 等. 甘糖酯抗氧化作用的分子机制[J]. 药学学报, 2004, 39(1):13-16. CHEN Xiao, LU Xinzhi, GAO Yan, et al. Molecular mechanisms of antioxidant effects of propylene glycol mannate sulfate[J]. Acta Pharmaceutica Sinica, 2004, 39(1):13-16.
[8] 张平, 夏泉, 赵新民. 甘糖酯的药理及临床应用研究进展[J]. 江苏药学与临床研究, 2001, 9(1):36-38.
[9] 滕继军. 甘糖酯对急性脑梗死病人中性粒细胞与内皮细胞黏附的影响[J]. 青岛大学医学院学报, 2003, 39(2):159-160. TENG Jijun. The effect of propylene glyco mannate sulfate on the adhesion between endothelial cells and polymorphonuclear neutrophils in acute cerebral infarction[J]. Acta Acad Med Qingdao Univ, 2003, 39(2):159-160.
[10] 张万科, 欧阳林旗, 罗志彪. 海洋藻类药物研究进展[J]. 海南医学, 2007, 18(6):123-124.
[11] Osaadon P, Fagan XJ, Lifshitz T, et al. A review of anti-VEGF agents for proliferative diabetic retinopathy[J]. Eye(Lond), 2014, 28(5):510-520.
[12] 许宇, 朱颖, 张琦, 等. 增生性糖尿病性视网膜病变围手术期Bevacizumab(Avastin)的应用[J]. 山东大学耳鼻喉眼学报,2010, 24(4):64-67. XU Yu, ZHU Ying, ZHANG Qi, et al. Preoperative use of intravitreal bevacizumab(avastin)for severe active proliferative diabetic retinopathy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2010, 24(4):64-67.
[13] Abu El-Asrar A M, Nawaz M I, Kangave D, et al. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy[J]. Acta Diabetol, 2013, 50(4):545-551.
[14] 谢丽. 糖尿病性黄斑水肿的治疗进展[J]. 山东大学耳鼻喉眼学报,2013,27(2):185-188. XIE Li. Treatment progress of diabetic macular edema[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2):81-85.
[15] Semeraro F, Cancarini A, Morescalchi F, et al. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients withtype 2 diabetes and proliferative retinopathy[J]. Diabetes Metab, 2014, 40(6):445-451.
[16] Mohan N, Monickaraj F, Balasubramanyam M, et al. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy[J]. J Diabetes Complications, 2012, 26(5):435-441.
[17] Ahn J, Woo SJ, Chung H, et al. The effect of adjunctive intravitreal bevacizumab for preventing post vitrectomy hemorrhage in proliferative diabetic retinopathy[J]. Ophthalmol, 2011, 118(11):2218-2226.
[18] 祝敏燕,韩丽荣. 糖尿病视网膜病变血浆与眼内液血管内皮生长因子的相关研究[J]. 中华眼底病杂志, 2004,20(6):343-345. ZHU Minyan, HAN Lirong. Investigation of concentration of vascular endothelial growth factor in plasma and intraocular liquid in diabetic retinopathy[J]. Chin J Ocular Fundus Dis, 2004, 20(6):343-345.
[19] Tuuminen R, Sahanne S, Loukovaara S. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment[J]. Acta Ophthalmol, 2014, 92(7):675-681.
[1] 李浩,李延忠,王岩. HIF-1α、VEGF在阻塞性睡眠呼吸暂停低通气综合征患者[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 43-47.
[2] 周学义,李一鸣,王美菊,张苑苑,张历浊. 25+微创玻璃体视网膜手术联合玻璃体腔注射雷珠单抗治疗增生型糖尿病视网膜病变的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 87-89.
[3] 王翠,颜昕,赵博军. IVR联合PDT治疗湿性年龄相关性黄斑变性的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 94-97.
[4] 邵娜,张晗. 糖尿病患者行白内障超声乳化术后视力及眼底的变化[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 83-87.
[5] 李盈盈, 周涵, 张伟强, 董伟达. 沉默HIF-1α基因对鼻黏膜上皮细胞生长因子表达的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 38-42.
[6] 李俊英. 瑞舒伐他汀联合非诺贝特对老年糖尿病视网膜病变患者血管内皮功能的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 72-75.
[7] 杜祥阁, 张营春, 颜昕, 王翠, 赵博军. 下调血管内皮细胞蛋白激酶CK2表达对血管增殖影响的体外研究[J]. 山东大学耳鼻喉眼学报, 2015, 29(3): 76-80.
[8] 张营春, 杜祥阁, 颜昕, 王翠, 赵博军. 尼古丁对人RPE细胞及HUVEC的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(2): 74-80.
[9] 刘志高, 颜世龙, 胡尊霞, 孙同鑫, 杨明, 王玉. 济南市农村白内障患者糖尿病及糖尿病视网膜眼底病变患病率调查分析[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 38-39.
[10] 马栋, 郭承伟. 络治法对STZ诱导的糖尿病大鼠视网膜血管消化铺片中VCAM-1表达的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 64-68.
[11] 刘海洋, 李甦雁, 张正培, 范巍. 改良膜分割与双手膜清除技术在23G玻璃体手术治疗增殖性糖尿病视网膜病变中的对比[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 52-55.
[12] 刘蓓1,朱忠桥1,杜善双1,王丽丽2,杨新光1. 前期激光及曲安奈德应用对增殖性糖尿病视网膜病变玻璃体切割手术的影响[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 66-68.
[13] 谢丽综述，魏伟审校. 糖尿病性黄斑水肿的治疗进展[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 81-85.
[14] 李俐华，任基浩, 殷团芳，刘伟. 儿童复发性呼吸道乳头状瘤组织中STAT3、VEGF的表达及微血管密度测定与复发、侵袭的关系[J]. 山东大学耳鼻喉眼学报, 2011, 25(6): 11-.
[15] 王淑雅，华宁，李筱荣 . 糖尿病性盲患者玻璃体手术后的脱盲率及未脱盲原因分析           [J]. 山东大学耳鼻喉眼学报, 2011, 25(6): 77-79.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 赵利敏，倪坤，吴佳丽，陈淑梅，李晓艳. 婴幼儿吸气性喉喘鸣病因分析与治疗[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 49 -51 .
[2] 史春生1，张庆泉2,王强2,孙岩2,葛长艺1. 软腭缺损修复组织瓣的特点[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 86 -88 .
[3] 张令1,孙传义1,许安廷2. 以耳聋就诊的岩尖胆脂瘤1例[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 93 -94 .
[4] 吴彦桥，邸斌，李军，高晓红 . 鼻内镜下难治性鼻出血出血点寻找及止血策略[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 1 -3 .
[5] 罗惠秀，范春涛，邓延华. 阻塞性睡眠呼吸暂停低通气综合征患儿扁桃体腺样体切除术临床疗效分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 17 -20 .
[6] 郝颖娟1，杨庆松2，周跃华2，易省平1，翟长斌2. 飞秒激光在薄瓣LASIK手术中制作的角膜瓣厚度形态观察[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 26 -31 .
[7] 闻华明1，李海祥2. 应用三角函数法估算LASIK术后人工晶状体度数[J]. 山东大学耳鼻喉眼学报, 2013, 27(5): 74 -76 .
[8] 朱见，贺青卿，郑鲁明，范子义，赵国伟，侯蕾，史后彬 . cN0甲状腺微小乳头状癌淋巴结转移高危因素及行预防性清扫临床分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(6): 9 -12 .
[9] 李少华，孙一帆，卢标清. 双软组织血管瓣填塞乳突术腔的临床研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 6 -7 .
[10] 魏希建1，阴瑞兰2，郭星3. 增殖诱导配体在喉鳞状细胞癌中的表达[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 14 -16 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发